# FDA 483 - Actavis Laboratories UT, Inc. - August 20, 2021

Source: https://www.globalkeysolutions.net/records/483/actavis-laboratories-ut-inc/101cbdfb-b214-4afb-b2fc-acfe03827d83

> FDA 483 for Actavis Laboratories UT, Inc. on August 20, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Actavis Laboratories UT, Inc.
- Inspection Date: 2021-08-20
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Actavis Laboratories UT, a wholly owned subsidiary of Teva Pharmaceutical, in Salt Lake City, UT, from August 16-20, 2021, identified one observation. The firm was cited for failing to properly store and segregate labeling materials from other drug components. This indicates a deficiency in their packaging and labeling system.

## Related Documents

- [483 - 2024-03-19](https://www.globalkeysolutions.net/records/483/actavis-laboratories-ut-inc/30da6e40-2e6e-45aa-88f1-15bfb9f5e13a)
- [483 - 2025-09-19](https://www.globalkeysolutions.net/records/483/actavis-laboratories-ut-inc/9bbbce85-4dac-4aa0-9a06-b6137bba0dac)

## Related Officers

- [Consumer Safety Officer (Drug Specialist)](https://www.globalkeysolutions.net/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41)
- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/dustin-m-james/bf423ddc-721b-4049-9eb1-3bc0fdb44441)

Company: https://www.globalkeysolutions.net/companies/actavis-laboratories-ut-inc/cbe6c043-14c7-4f58-84bf-68647da581f8

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face